These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35792512)

  • 1. Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2022 Sep; 620():150-157. PubMed ID: 35792512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2023 May; 656():146-147. PubMed ID: 36966045
    [No Abstract]   [Full Text] [Related]  

  • 3. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
    Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
    Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chb-M', an Inhibitor of the RUNX Family Binding to DNA, Induces Apoptosis in
    Hirose Y; Sato S; Hashiya K; Ooga M; Bando T; Sugiyama H
    J Med Chem; 2024 Jun; 67(11):9165-9172. PubMed ID: 38803164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Alkylation of the RUNX-Binding Sequence by CBI-PI Polyamide Conjugates*.
    Maeda R; Ito S; Hashiya K; Bando T; Sugiyama H
    Chemistry; 2020 Nov; 26(64):14639-14644. PubMed ID: 32672369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
    Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
    Daifu T; Mikami M; Hiramatsu H; Iwai A; Umeda K; Noura M; Kubota H; Masuda T; Furuichi K; Takasaki S; Noguchi Y; Morita K; Bando T; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28789. PubMed ID: 33180377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.
    Doucette TA; Yang Y; Pedone C; Kim JY; Dubuc A; Northcott PD; Taylor MD; Fults DW; Rao G
    Neurosurgery; 2012 Apr; 70(4):1003-10; discussion 1010. PubMed ID: 22037313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenovin-6 exhibits inhibitory effects on the growth of Sonic Hedgehog (SHH) medulloblastoma, as evidenced by both in vitro and in vivo studies.
    Wang B; Xu T; Qiu C; Yu L; Xu S; Zhao X; Xu C; Tan F; Sheng H; Zhang N
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113075. PubMed ID: 39260312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX inhibitor suppresses graft-versus-host disease through targeting
    Kubota H; Masuda T; Noura M; Furuichi K; Matsuo H; Hirata M; Kataoka TR; Hiramatsu H; Yasumi T; Nakahata T; Imai Y; Takita J; Adachi S; Sugiyama H; Kamikubo Y
    EJHaem; 2021 Aug; 2(3):449-458. PubMed ID: 35844683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Shi X; Wang Q; Gu J; Xuan Z; Wu JI
    Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 inhibitor MDM2 facilitates Sonic Hedgehog-mediated tumorigenesis and influences cerebellar foliation.
    Malek R; Matta J; Taylor N; Perry ME; Mendrysa SM
    PLoS One; 2011 Mar; 6(3):e17884. PubMed ID: 21437245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHH inhibitors for the treatment of medulloblastoma.
    Samkari A; White J; Packer R
    Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
    Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
    Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA
    Kaushik I; Srivastava SK
    Mol Ther; 2022 Jul; 30(7):2584-2602. PubMed ID: 35331907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
    Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
    Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.
    Yoon JW; Gilbertson R; Iannaccone S; Iannaccone P; Walterhouse D
    Int J Cancer; 2009 Jan; 124(1):109-19. PubMed ID: 18924150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
    Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.